Xenetic Biosciences, a biopharmaceutical company focused on developing next-generation biologic drugs and novel oncology therapeutics, has opened its new corporate headquarters and R&D facility in Lexington, Mass. Xenetic relocated its global headquarters to Lexington from London.

The company currently has seven employees in Lexington with plans to grow to 14 by the end of 2014.